Peter Brady

A week is a long time in politics – particularly true of the last seven days. But what does Brexit mean for life sciences? What's next for the UK's medtech, pharma and digital health sectors? more

Jul 1, 2016 10:27 AM Opinion

Peter Brady, CEO at UK-based medical device software firm Ascensys Medical shares his thoughts on what the referendum outcome means for medical devices manufacturers more

Jun 28, 2016 10:33 AM Opinion